2013 Q1 Form 10-Q Financial Statement

#000117891313000203 Filed on January 31, 2013

View on sec.gov

Income Statement

Concept 2013 Q1 2012 Q4 2011 Q4
Revenue $194.0K $195.0K $231.00
YoY Change -15.65% 84315.58%
Cost Of Revenue $6.000K $6.000K $7.00
YoY Change 0.0% 85614.29%
Gross Profit $188.0K $189.0K $224.00
YoY Change -16.07% 84275.0%
Gross Profit Margin 96.91% 96.92% 96.97%
Selling, General & Admin $1.160M $1.420M $1.280M
YoY Change -39.58% 10.94% 2.4%
% of Gross Profit 617.02% 751.32% 571428.57%
Research & Development $4.965M $4.146M $2.969K
YoY Change 45.13% 139542.98% -99.86%
% of Gross Profit 2640.96% 2193.65% 1325.45%
Depreciation & Amortization $310.0K $150.0K $100.0K
YoY Change 181.82% 50.0% 42.86%
% of Gross Profit 164.89% 79.37% 44642.86%
Operating Expenses $4.965M $4.146M $2.349M
YoY Change 2.58% 76.5% -16.82%
Operating Profit -$5.933M -$4.884M -$2.118K
YoY Change 28.7% 230494.9% -99.93%
Interest Expense $250.0K $390.0K $130.0K
YoY Change -43.18% 200.0%
% of Operating Profit
Other Income/Expense, Net $253.0K $394.0K
YoY Change
Pretax Income -$5.680M -$4.490M -$1.990M
YoY Change 36.21% 125.63% -29.43%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.680M -$4.490M -$1.992K
YoY Change 36.08% 225301.61% -99.93%
Net Earnings / Revenue -2927.84% -2302.56% -862.34%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.97 -$0.78 -$0.46
COMMON SHARES
Basic Shares Outstanding 58.33M 57.40M 43.78M
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q1 2012 Q4 2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $59.83M $64.57M $41.52M
YoY Change 51.32% 55.52% 775.95%
Cash & Equivalents $27.82M $23.55M $6.672K
Short-Term Investments $32.01M $41.03M $34.84M
Other Short-Term Assets $220.0K
YoY Change 266.67%
Inventory
Prepaid Expenses $217.0K
Receivables $2.110M
Other Receivables $0.00
Total Short-Term Assets $61.11M $66.27K $43.84M
YoY Change 47.41% -99.85% 692.82%
LONG-TERM ASSETS
Property, Plant & Equipment $11.50M $10.03K $2.883M
YoY Change 275.11% -99.65% 58.41%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $790.0K $760.0K $1.190M
YoY Change 12.86% -36.13% 561.11%
Other Assets $113.0K $1.305K $1.245M
YoY Change -90.22% -99.9% 245.83%
Total Long-Term Assets $13.23M $12.85K $5.799M
YoY Change 143.1% -99.78% 146.77%
TOTAL ASSETS
Total Short-Term Assets $61.11M $66.27K $43.84M
Total Long-Term Assets $13.23M $12.85K $5.799M
Total Assets $74.34M $79.12K $49.64M
YoY Change 58.51% -99.84% 529.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.577M $3.397K $1.174M
YoY Change 68.54% -99.71% 26.24%
Accrued Expenses $780.0K $426.00 $231.0K
YoY Change 239.13% -99.82% 156.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.765M $6.126K $4.976M
YoY Change 18.77% -99.88% 236.22%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $709.0K $3.950M $4.310M
YoY Change -82.87% -8.35% 926.19%
Total Long-Term Liabilities $4.553M $3.950K $4.314M
YoY Change 9.95% -99.91% 927.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.765M $6.126K $4.976M
Total Long-Term Liabilities $4.553M $3.950K $4.314M
Total Liabilities $10.32M $10.08K $9.290M
YoY Change 14.71% -99.89% 388.95%
SHAREHOLDERS EQUITY
Retained Earnings -$79.91M -$74.23K -$57.44M
YoY Change 29.7% -99.87%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $64.02M $69.04M $40.35K
YoY Change
Total Liabilities & Shareholders Equity $74.34M $79.12K $49.64M
YoY Change 58.51% -99.84% 529.97%

Cashflow Statement

Concept 2013 Q1 2012 Q4 2011 Q4
OPERATING ACTIVITIES
Net Income -$5.680M -$4.490M -$1.992K
YoY Change 36.08% 225301.61% -99.93%
Depreciation, Depletion And Amortization $310.0K $150.0K $100.0K
YoY Change 181.82% 50.0% 42.86%
Cash From Operating Activities -$4.980M -$3.370M -$3.290M
YoY Change 97.62% 2.43% 115.03%
INVESTING ACTIVITIES
Capital Expenditures -$90.00K $1.360M $820.0K
YoY Change -129.03% 65.85% 530.77%
Acquisitions
YoY Change
Other Investing Activities $9.150M -$10.93M -$2.940M
YoY Change 17.61% 271.77% -688.0%
Cash From Investing Activities $9.240M -$12.29M -$3.750M
YoY Change 24.03% 227.73% -1113.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 30.00K 450.0K 80.00K
YoY Change 462.5% -98.33%
NET CHANGE
Cash From Operating Activities -4.980M -3.370M -3.290M
Cash From Investing Activities 9.240M -12.29M -3.750M
Cash From Financing Activities 30.00K 450.0K 80.00K
Net Change In Cash 4.290M -15.21M -6.960M
YoY Change -12.98% 118.53% -292.27%
FREE CASH FLOW
Cash From Operating Activities -$4.980M -$3.370M -$3.290M
Capital Expenditures -$90.00K $1.360M $820.0K
Free Cash Flow -$4.890M -$4.730M -$4.110M
YoY Change 72.79% 15.09% 147.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2012-12-31
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001158780
CY2013Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
58333206
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
PLURISTEM THERAPEUTICS INC
psti Additional Shares Commited For Issuance
AdditionalSharesCommitedForIssuance
75
psti Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities
AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities
53 USD
psti Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities
AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities
-33 USD
CY2012Q4 psti Available For Sale Securities Gross Unrealized Gain Aggregate
AvailableForSaleSecuritiesGrossUnrealizedGainAggregate
417 USD
CY2012Q2 psti Available For Sale Securities Gross Unrealized Gain Aggregate
AvailableForSaleSecuritiesGrossUnrealizedGainAggregate
94 USD
CY2012Q4 psti Available For Sale Securities Gross Unrealized Gain Matures After Five Year Through Ten Years
AvailableForSaleSecuritiesGrossUnrealizedGainMaturesAfterFiveYearThroughTenYears
66 USD
CY2012Q2 psti Available For Sale Securities Gross Unrealized Gain Matures After Five Year Through Ten Years
AvailableForSaleSecuritiesGrossUnrealizedGainMaturesAfterFiveYearThroughTenYears
3 USD
CY2012Q4 psti Available For Sale Securities Gross Unrealized Gain Matures After One Year Through Five Years
AvailableForSaleSecuritiesGrossUnrealizedGainMaturesAfterOneYearThroughFiveYears
209 USD
CY2012Q2 psti Available For Sale Securities Gross Unrealized Gain Matures After One Year Through Five Years
AvailableForSaleSecuritiesGrossUnrealizedGainMaturesAfterOneYearThroughFiveYears
32 USD
CY2012Q4 psti Available For Sale Securities Gross Unrealized Loss Aggregate
AvailableForSaleSecuritiesGrossUnrealizedLossAggregate
53 USD
CY2012Q2 psti Available For Sale Securities Gross Unrealized Loss Aggregate
AvailableForSaleSecuritiesGrossUnrealizedLossAggregate
224 USD
CY2012Q4 psti Available For Sale Securities Gross Unrealized Loss Matures After Five Year Through Ten Years
AvailableForSaleSecuritiesGrossUnrealizedLossMaturesAfterFiveYearThroughTenYears
USD
CY2012Q2 psti Available For Sale Securities Gross Unrealized Loss Matures After Five Year Through Ten Years
AvailableForSaleSecuritiesGrossUnrealizedLossMaturesAfterFiveYearThroughTenYears
67 USD
CY2012Q4 psti Available For Sale Securities Gross Unrealized Loss Matures After One Year Through Five Years
AvailableForSaleSecuritiesGrossUnrealizedLossMaturesAfterOneYearThroughFiveYears
2 USD
CY2012Q2 psti Available For Sale Securities Gross Unrealized Loss Matures After One Year Through Five Years
AvailableForSaleSecuritiesGrossUnrealizedLossMaturesAfterOneYearThroughFiveYears
99 USD
psti Exercise Of Warrants By Investors And Finders
ExerciseOfWarrantsByInvestorsAndFinders
1679 USD
psti Exercise Of Warrants By Investors And Finders
ExerciseOfWarrantsByInvestorsAndFinders
371 USD
psti Financial Income Expense Net
FinancialIncomeExpenseNet
589 USD
psti Financial Income Expense Net
FinancialIncomeExpenseNet
-35 USD
CY2012Q4 psti Financial Income Expense Net
FinancialIncomeExpenseNet
394 USD
CY2011Q4 psti Financial Income Expense Net
FinancialIncomeExpenseNet
126 USD
psti Issuance Of Common Stock And Warrants Related To September2012 Public Offering
IssuanceOfCommonStockAndWarrantsRelatedToSeptember2012PublicOffering
34106 USD
CY2012Q3 psti Limited Period Number Of Common Stock Options
LimitedPeriodNumberOfCommonStockOptions
1200000
CY2012Q3 psti Limited Period Number Of Common Stock Options And Or Warrants Maximum
LimitedPeriodNumberOfCommonStockOptionsAndOrWarrantsMaximum
420000
psti Linkage Differences And Interest On Short And Long Term Restricted Lease Deposit
LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit
-102 USD
psti Linkage Differences And Interest On Short And Long Term Restricted Lease Deposit
LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit
-213 USD
CY2012Q4 psti Other Long Term Assets
OtherLongTermAssets
59 USD
CY2012Q2 psti Other Long Term Assets
OtherLongTermAssets
USD
psti Participation By Office Of Chief Scientist And Other Parties
ParticipationByOfficeOfChiefScientistAndOtherParties
1543 USD
psti Stock Based Compensation To Employees Directors And Non Employees Consultants
StockBasedCompensationToEmployeesDirectorsAndNonEmployeesConsultants
3164 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3397 USD
CY2012Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1368 USD
CY2012Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
925 USD
CY2012Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
877 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
426 USD
CY2012Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
922 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
364 USD
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-130 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
142912 USD
CY2012Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
103619 USD
CY2012Q4 us-gaap Assets
Assets
79120 USD
CY2012Q2 us-gaap Assets
Assets
47420 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
66272 USD
CY2012Q2 us-gaap Assets Current
AssetsCurrent
38192 USD
psti Participation By Office Of Chief Scientist And Other Parties
ParticipationByOfficeOfChiefScientistAndOtherParties
1921 USD
CY2012Q4 psti Participation By Office Of Chief Scientist And Other Parties
ParticipationByOfficeOfChiefScientistAndOtherParties
493 USD
CY2011Q4 psti Participation By Office Of Chief Scientist And Other Parties
ParticipationByOfficeOfChiefScientistAndOtherParties
1902 USD
CY2012Q3 psti Public Offering Number Of Shares Per Unit
PublicOfferingNumberOfSharesPerUnit
1
CY2012Q3 psti Public Offering Number Of Shares To Be Purchased Per One Warrant
PublicOfferingNumberOfSharesToBePurchasedPerOneWarrant
0.35
CY2012Q3 psti Public Offering Number Of Warrants Per Unit
PublicOfferingNumberOfWarrantsPerUnit
1
CY2012Q3 psti Public Offering Purchase Price Per Unit
PublicOfferingPurchasePricePerUnit
4.0
psti Purchase Of Property And Equipment In Credit
PurchaseOfPropertyAndEquipmentInCredit
588 USD
psti Purchase Of Property And Equipment In Credit
PurchaseOfPropertyAndEquipmentInCredit
121 USD
psti Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
6351 USD
psti Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
3911 USD
CY2012Q4 psti Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
3653 USD
CY2011Q4 psti Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
1067 USD
psti Sharebased Compensation Arrangement Warrants Exercised
SharebasedCompensationArrangementWarrantsExercised
718213
psti Share Based Compensation To Employees Directors And Non Employees
ShareBasedCompensationToEmployeesDirectorsAndNonEmployees
1684 USD
psti Share Based Compensation To Employees Directors And Non Employees
ShareBasedCompensationToEmployeesDirectorsAndNonEmployees
1904 USD
psti Stock Based Compensation To Contractor
StockBasedCompensationToContractor
1400 USD
psti Stock Based Compensation To Contractor
StockBasedCompensationToContractor
1245 USD
psti Stock Based Compensation To Employees Directors And Non Employees Consultants
StockBasedCompensationToEmployeesDirectorsAndNonEmployeesConsultants
1962 USD
CY2012Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
12848 USD
CY2012Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
9228 USD
CY2012Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
1266 USD
CY2012Q2 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
1283 USD
CY2012Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
1332 USD
CY2012Q2 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
1219 USD
CY2012Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
5060 USD
CY2012Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
4246 USD
CY2012Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
5267 USD
CY2012Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
4179 USD
CY2012Q4 us-gaap Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
8518 USD
CY2012Q2 us-gaap Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
7153 USD
CY2012Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
2192 USD
CY2012Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
1624 USD
CY2012Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2283 USD
CY2012Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1625 USD
CY2012Q4 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
8882 USD
CY2012Q2 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
7023 USD
CY2012Q4 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
142 USD
CY2012Q2 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
59 USD
CY2012Q4 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
51 USD
CY2012Q2 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
58 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23548 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9389 USD
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42829 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6672 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14159 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-36157 USD
CY2012Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
5.0
CY2012Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
446423
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0
CY2012Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58331956
CY2012Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46448051
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
58331956
CY2012Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46448051
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
USD
CY2012Q2 us-gaap Common Stock Value
CommonStockValue
USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7991 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6619 USD
CY2012Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4225 USD
CY2011Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2127 USD
us-gaap Cost Of Revenue
CostOfRevenue
12 USD
us-gaap Cost Of Revenue
CostOfRevenue
12 USD
CY2012Q4 us-gaap Cost Of Revenue
CostOfRevenue
6 USD
CY2011Q4 us-gaap Cost Of Revenue
CostOfRevenue
7 USD
CY2012Q4 us-gaap Customer Advances Current
CustomerAdvancesCurrent
599 USD
CY2012Q2 us-gaap Customer Advances Current
CustomerAdvancesCurrent
1576 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
779 USD
CY2012Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
779 USD
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3116 USD
CY2012Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3505 USD
CY2012Q4 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
702 USD
CY2012Q2 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
522 USD
CY2012Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
756 USD
CY2012Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
1287 USD
us-gaap Depreciation
Depreciation
276 USD
us-gaap Depreciation
Depreciation
199 USD
CY2012Q4 us-gaap Derivative Asset Fair Value Net
DerivativeAssetFairValueNet
204 USD
CY2012Q2 us-gaap Derivative Asset Fair Value Net
DerivativeAssetFairValueNet
-138 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2012Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2011Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
808 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3101 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2912 USD
CY2012Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1420 USD
CY2011Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1275 USD
us-gaap Gross Profit
GrossProfit
378 USD
us-gaap Gross Profit
GrossProfit
373 USD
CY2012Q4 us-gaap Gross Profit
GrossProfit
189 USD
CY2011Q4 us-gaap Gross Profit
GrossProfit
224 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
3 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
10 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2179 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-48 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
112 USD
us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
-977 USD
us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
1926 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-389 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4615 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
577 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-97 USD
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
525 USD
us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
-10646 USD
us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
-30273 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1960 USD
us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
3 USD
us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
13 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
278 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
79120 USD
CY2012Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47420 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6126 USD
CY2012Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5522 USD
CY2012Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3950 USD
CY2012Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4156 USD
CY2012Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
8882 USD
CY2012Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
7023 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-23 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
35944 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
400 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14895 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36731 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6890 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
174 USD
us-gaap Net Income Loss
NetIncomeLoss
-8485 USD
us-gaap Net Income Loss
NetIncomeLoss
-6485 USD
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-4490 USD
CY2011Q4 us-gaap Net Income Loss
NetIncomeLoss
-1992 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-9074 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6450 USD
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-4884 USD
CY2011Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2118 USD
CY2011Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2969 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-74232 USD
CY2012Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65747 USD
us-gaap Revenues
Revenues
390 USD
us-gaap Revenues
Revenues
385 USD
CY2012Q4 us-gaap Revenues
Revenues
195 USD
CY2011Q4 us-gaap Revenues
Revenues
231 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1305 USD
CY2012Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2400 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
494 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-134 USD
CY2012Q4 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
265 USD
CY2011Q4 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-135 USD
CY2012Q3 us-gaap Partners Capital Account Units Sold In Public Offering
PartnersCapitalAccountUnitsSoldInPublicOffering
8000000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-521 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1011 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2694 USD
us-gaap Payments To Acquire Available For Sale Securities Equity
PaymentsToAcquireAvailableForSaleSecuritiesEquity
2204 USD
us-gaap Payments To Acquire Available For Sale Securities Equity
PaymentsToAcquireAvailableForSaleSecuritiesEquity
4503 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3338 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
996 USD
CY2012Q4 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
834 USD
CY2012Q2 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
651 USD
CY2012Q4 us-gaap Prior Period Reclassification Adjustment
PriorPeriodReclassificationAdjustment
12 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
34106 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1838 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
400 USD
CY2012Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
34106 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
763 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
50 USD
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
9 USD
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
2 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10026 USD
CY2012Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5019 USD
CY2012Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
1699 USD
CY2012Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
383 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7894 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5832 USD
CY2012Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4146 USD
CY2012Q4 us-gaap Short Term Investments
ShortTermInvestments
32143 USD
CY2012Q2 us-gaap Short Term Investments
ShortTermInvestments
21397 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
69044 USD
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
37742 USD
CY2011Q2 us-gaap Stockholders Equity
StockholdersEquity
43422 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
40352 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
146 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
52659430
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
43225017
CY2012Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
57512930
CY2011Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
43669466

Files In Submission

Name View Source Status
0001178913-13-000203-index-headers.html Edgar Link pending
0001178913-13-000203-index.html Edgar Link pending
0001178913-13-000203.txt Edgar Link pending
0001178913-13-000203-xbrl.zip Edgar Link pending
exhibit_31-1.htm Edgar Link pending
exhibit_31-2.htm Edgar Link pending
exhibit_32-1.htm Edgar Link pending
exhibit_32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
psti-20121231.xml Edgar Link completed
psti-20121231.xsd Edgar Link pending
psti-20121231_cal.xml Edgar Link unprocessable
psti-20121231_def.xml Edgar Link unprocessable
psti-20121231_lab.xml Edgar Link unprocessable
psti-20121231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zk1312548.htm Edgar Link pending